Yapan Bio
Tracked across 5 events · 61 articles · First seen Apr 28, 2026 · Last active Aug 18, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
On August 18, 2026, Piramal Group (PPL) completed the acquisition of an additional 40.67% stake in Yapan Bio, a Hyderabad-based CDMO specializing in vaccines and biologics, for a cash consideration of ₹76 crore (approximately $7.95…
Impact: Target; became a subsidiary of Piramal Pharma, gaining access to broader resources and integration into PPL's global network.
Jul 20, 2026 · 11 articles
Business
Impact: Piramal Group has a strategic minority investment in Yapan Bio, which operates in the biologics/bio-therapeutics and vaccine segments.
Apr 28, 2026 · 14 articles
Business
Impact: Piramal Group has a strategic minority investment in Yapan Bio, which operates in biologics and vaccines.
Jul 07, 2026 · 14 articles
Business
Piramal Enterprises — Piramal Pharma Solutions (PPS), a CDMO and part of Piramal Group, launched a new spray drying suite at its dedicated peptide development and manufacturing facility in Turbhe, India. The suite is a…
Impact: Associate company of Piramal Pharma; not directly involved in this expansion.
Aug 04, 2026 · 12 articles
Business
Impact: Piramal Group has a strategic minority investment in Yapan Bio, which operates in biologics and vaccine segments.
Jul 29, 2026 · 10 articles
100
Piramal Group acquired Yapan BioPiramal Pharma acquires...
ERGEN INTELLIGENCE
Track Yapan Bio live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard